IAXO-102
目录号: PL12345 纯度: ≥98.0%
CAS No. :1115270-63-7
商品编号 规格 价格 会员价 是否有货 数量
PL12345-5mg 5mg ¥5625.00 请登录
PL12345-10mg 10mg ¥8840.00 请登录
PL12345-50mg 50mg ¥26520.00 请登录
PL12345-100mg 100mg ¥42592.00 请登录
PL12345-200mg 200mg 询价 询价
PL12345-500mg 500mg 询价 询价
PL12345-10mM*1mLinEthanol 10mM*1mLinEthanol ¥7248.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
IAXO-102
英文名称
IAXO-102
英文别名
(2R,3R,4S,5R,6S)-2-(Aminomethyl)-6-methoxy-4,5-di(tetradecoxy)oxan-3-ol;IAXO-102
Cas No.
1115270-63-7
分子式
C35H71NO5
分子量
585.94
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
IAXO-102 是 TLR4 的拮抗剂,抑制 TLR4 信号通路。IAXO-102 抑制 MAPK 和 p65 NF-kB 的磷酸化及 TLR4 和 TLR4 依赖性的炎性蛋白的表达。IAXO-102 抑制实验性腹主动脉瘤的发展。
生物活性
IAXO-102 is a TLR4 antagonist which negatively regulates TLR4 signalling. IAXO-102 inhibits MAPK and p65 NF-κB phosphorylation and expression of TLR4 dependent proinflammatory protein. IAXO-102 also prevents experimental abdominal aortic aneurysm development.
性状
Solid
IC50 & Target[1][2]
TLR4
体外研究(In Vitro)
IAXO-102 (1-10 μM, for 2 hours) inhibits MAPK and p65 NF-κB phosphorylation in human umbilical vein endothelial (HUVEC) cells.
IAXO-102 (10 μM, for 17 hours) suppresses LPS induced proinflammatory proteins MCP-1 and IL-8 production in HUVEC. has not independently confirmed the accuracy of these methods. They are for reference only.Western Blot Analysis
体内研究(In Vivo)
IAXO-102 (3 mg/kg/day, s.c. for 28 days) significantly retards Angiotensin II induced increase in aortic diameter in mice. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Six-monthold
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Huggins C, et al. A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development. Atherosclerosis. 2015 Oct;242(2):563-70.
溶解度数据
In Vitro: Ethanol : 50 mg/mL (85.33 mM; Need ultrasonic)DMSO : 5 mg/mL (8.53 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2